US FDA accepts Biologics License Application for Horizon Therapeutics' Teprotumumab
US FDA grants Orphan Drug designation to Acceleron Pharma's Sotatercept
Wize Pharma signs exclusive license contract with Copernicus Therapeutics
Acceleron Receives FDA Orphan Drug Designation for Sotatercept in Pulmonary Arterial Hypertension
Acceleron Receives FDA Orphan Drug Designation for Sotatercept in Pulmonary Arterial Hypertension
US FDA grants Breakthrough Therapy designation to Ridgeback Biotherapeutics' Ebola treatment
US FDA approves Ofev (nintedanib) capsules
US FDA grants SunGen Pharma seventh ANDA approval for Fosapreptant
US FDA grants approval to Novitium Pharma's Biovitrum's Orfadin
VeraSci announces FDA grant to support qualification of VRFCAT
Sagent Pharmaceuticals gets FDA clearance for Omega manufacturing site